The bariatric beds market is expected to increase from US$ 297.08 million in 2023 to US$ 497.92 million in 2033. The market is likely to capture a 5.3% CAGR from 2023 to 2033.
The Increase in Global Obesity is driving the need for Bariatric Beds
Factors that are expected to drive market expansion include:
Bariatrics is a specialty of medicine that treats persons who are overweight. The key parameters involved in determining a bariatric patient are the patient's weight and the overall distribution of weight throughout the body.
Obese patients are typically identified with the help of the Body Mass Index (BMI). Many hospitals are now embracing bariatrics as a separate specialty. A bariatric bed is specifically built to meet the needs and comfort of obese individuals.
Bariatric beds have extensive obligation outlines, a high weight capacity, and several movable highlights for the comfort and flexibility of the patient. Increasing health concerns such as heart disease have motivated people to seek bariatric surgery. The worldwide bariatric beds market is likely to be driven by improved patient experience and comfort.
| Report Attribute | Details |
|---|---|
| Bariatric Beds Market Value (2023) | US$ 297.08 million |
| Bariatric Beds Market Anticipated Value (2033) | US$ 497.92 million |
| Bariatric Beds Market Growth Rate (2023 to 2033) | 5.3% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The bariatric beds market accounted for US$ 282.13 million in 2022, expanding at a 5% CAGR from 2018 to 2022.
Sedentary lifestyles, greater consumption of unhealthy foods, an increase in bariatric surgery, and rare genetic diseases leading to obesity. Prader-Willi syndrome, hypothyroidism, and Cushing's syndrome are among the causes driving growth in the worldwide bariatric beds market.
Furthermore, the rising obesity rate is expected to fuel the worldwide bariatric beds market. According to the World Health Organization (WHO), an estimated 650 million people worldwide were obese in 2016. These figures also revealed that an estimated 1.9 billion individuals worldwide were overweight, adding to the demand for bariatric beds.
High initial acquisition costs of bariatric beds, combined with higher maintenance costs, are important issues that can stymie the global bariatric beds market's growth.
Increasing demand for preoperative and postoperative bariatric procedures, increased use of current technology, and expansion of healthcare infrastructure are expected to drive market growth soon. Rising approval and product launch are two more elements that can drive market expansion. Hefty maintenance costs and early acquisition costs can stifle market growth.
| Historical CAGR (2018 to 2022) | 5% |
|---|---|
| Forecast CAGR (2023 to 2033) | 5.3% |
As per the FMI analysts, a valuation of US$ 497.92 million by 2033 end is estimated for the market.
| Year | Market Valuation |
|---|---|
| 2016 | US$ 206.95 million |
| 2021 | US$ 267.93 million |
| 2022 | US$ 282.13 million |
| 2023 | US$ 297.08 million |
| 2033 | US$ 497.92 million |
The rising consumption of unhealthy foods is expected to boost the worldwide bariatric beds' industry. Increasing sedentary lifestyle adoption, as well as an increase in bariatric operations, are expected to support the growth of the market. Additionally, the rising obesity rate is likely to raise the bariatric bed market share.
Principal Consultant
Bariatric surgery was always seen to be a last resort for weight loss; nevertheless, it has grown in popularity over the years. Since it is safer and more effective than normal medical procedures, such as drugs and dietary counseling. Over the last decade, several bariatric surgeries performed worldwide have steadily increased.
The overall count of bariatric procedures performed in the United States was 158,000 in 2011, according to the American Society for Metabolic and Bariatric Surgery (ASMBS). The rise in bariatric operations is predicted to increase demand for associated equipment and gadgets. Following this, bariatric surgery is the most effective and long-term treatment for morbid obesity and a variety of linked illnesses.
Obesity is still a big public health issue around the world. Those with obesity incurred medical costs that were US$ 1,861 more than those with a healthy weight. Bariatric surgery is an effective treatment for extreme obesity. Resulting in the improvement or remission of many obesity-related comorbid disorders, long-term weight loss, and overall enhanced quality of life.
Developing markets such as India and South Korea are working hard to establish a regulatory framework. This framework distinguishes between medical devices and pharmaceutical devices and instruments. Because there is no clear separation between medications and devices, the clearance process is currently unstable, resulting in delays. As a result, unstable regulatory frameworks are projected to lengthen the clearance process for surgical equipment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Laparoscopic or minimally invasive bariatric surgery has many advantages, including fewer wound complications, shorter hospital stays, and less pain. Internal hernias, gastroesophageal reflux disease (GERD), chronic nausea and vomiting, severe dumping syndrome, ulcers, malnutrition, and inflammatory bowel disease are all risks linked with these operations.
A gastric balloon, also known as an intragastric balloon (IGB) or a stomach balloon, is a temporary medical device that is put into the stomach to aid with weight loss. Factors such as:
The ReShape Duo Balloon and the ORBERA Balloon are two approved gastric balloons in the United States. Spatz Medical said in May 2019 that their newly launched Spatz3 balloon is much more successful than any non-adjustable balloon, as determined by the USFDA. Nonetheless, market participants have used a variety of techniques, including funding and product launch processes.
Allurion Technologies, a manufacturer of gastric weight-loss balloons, has boosted its funding by US$ 34 million to speed its commercialization efforts and entry into the United States market for its Elipse Balloon. As a result, the gastric balloon segment is predicted to grow.
The rising incidence of chronic conditions such as diabetes, in North America, is likely to lead the worldwide bariatric beds market during the forecast period. The increased acceptance of unhealthy lifestyles is also expected to boost the region's market.
According to the Centres for Disease Control and Prevention (CDC), 39.8% of the United States population, or 93.3 million people, were obese in 2015 to 2016.
Increasing life expectancy in this region is predicted to increase demand for home healthcare and long-term care services, driving the market in North America. Moreover, factors that are likely to drive the market growth include:
Increasing healthcare expenditure in this region is likely to drive technical developments in the healthcare market. Advantageous reimbursement rules and increased government spending in long-term healthcare. Additionally, expanding infrastructure for healthcare research is among the variables that are predicted to increase the use of bariatric beds.
Due to an increase in many bariatric operations, the bariatric beds market in Europe is likely to develop throughout the forecast period. According to the National Bariatric Surgery Registry, 5,704 bariatric surgeries were reported in the United Kingdom between 2015 and 2016.
Throughout the projection period, Asia Pacific is expected to have the highest growth rate of 6.0%. The increased prevalence of chronic diseases is a result of bad eating habits, excessive cigarette smoking, and the rising need for cost-effective treatments. Furthermore, with rapidly increasing purchasing power, a higher proportion of the population pays for its healthcare needs and lavishes money on technologically improved healthcare services.
The rising prevalence of dyslipidemia. The rise in the incidence of type 2 diabetes mellitus, lack of physical exercise, and rise in the obese population are all positively impacting the Asia Pacific global bariatric beds market. Because of substantial public and private research expenditures and the availability of technologically advanced items.
In 2022, the 500-700 lbs category led the market, accounting for more than 41% of the total. Bariatric beds with weight capacities of 500-700 lbs are more comfortable and can accommodate more prospective patients. Additionally, 500-700-pound bariatric beds allow for customizable placement, which significantly modifies the bed's construction. As an added benefit, side rails prevent patients from collapsing during surgical operations or while exiting or entering the bed. As a result, increased benefits associated with 500-700 lbs bariatric beds, as well as an increase in its adoption rate, are likely to fuel industry growth.
In 2022, the hospital segment led the end-use segment. When compared to other healthcare settings, hospitals see a substantially higher influx of patients for a variety of surgeries. This includes bariatric surgery, due to the simplicity of managing any emergencies that may develop during surgical procedures. Moreover, the availability of a wide range of treatment alternatives.
This is due to an increase in the obese population, an increase in the demand for bariatric surgery for preoperative and postoperative procedures, and skilled staff.
To maintain their market position, several firms in the bariatric beds market are pursuing various growth strategies such as strategic partnerships and collaborations, product approval and launches, mergers and acquisitions, and joint ventures. Because the leading market participants are spending on research and development to develop cost-effective and efficient bariatric beds, the industry is competitive.
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | US$ 297.08 million |
| Market Size Value at End of Forecast (2033) | US$ 497.92 million |
| Market Analysis | US$ million for Value |
| Key Region Covered | North America; Europe; Asia Pacific; Latin America; The Middle East & Africa |
| Key Segments | By Weight Capacity, By End Use, By Region |
| Key Companies Profiled | Invacare Corporation; Hill-Rom holdings; Stryker; Arjo; Drive DeVilbiss Healthcare; Gf Health Products; Zhangjiagang Medi; Cobi Rehab; Alerta; Rotec International |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The expansion in the elderly population drives sales.
North America is anticipated to be the market with the high potential.
The market is forecast to register a CAGR of 5.3% through 2033.
The market is valued at US$ 297.08 million in 2023.
The introduction of bariatric patient mattresses boosts the industry's revenue.
1. Executive Summary | Bariatric Beds Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Weight Capacity
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Weight Capacity, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Weight Capacity, 2023 to 2033
5.3.1. 500-700 lbs
5.3.2. 700-1000 lbs
5.3.3. >1000 lbs
5.4. Y-o-Y Growth Trend Analysis By Weight Capacity, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Weight Capacity, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033
6.3.1. Hospitals
6.3.2. Nursing Homes
6.4. Y-o-Y Growth Trend Analysis By End-use, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. The USA
8.2.1.2. Canada
8.2.2. By Weight Capacity
8.2.3. By End-use
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Weight Capacity
8.3.3. By End-use
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Weight Capacity
9.2.3. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Weight Capacity
9.3.3. By End-use
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Weight Capacity
10.2.3. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Weight Capacity
10.3.3. By End-use
10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Weight Capacity
11.2.3. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Weight Capacity
11.3.3. By End-use
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Weight Capacity
12.2.3. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Weight Capacity
12.3.3. By End-use
12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Weight Capacity
13.2.3. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Weight Capacity
13.3.3. By End-use
13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Weight Capacity
14.2.3. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Weight Capacity
14.3.3. By End-use
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Weight Capacity
15.1.2.2. By End-use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Weight Capacity
15.2.2.2. By End-use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Weight Capacity
15.3.2.2. By End-use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Weight Capacity
15.4.2.2. By End-use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Weight Capacity
15.5.2.2. By End-use
15.6. United Kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Weight Capacity
15.6.2.2. By End-use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Weight Capacity
15.7.2.2. By End-use
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Weight Capacity
15.8.2.2. By End-use
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Weight Capacity
15.9.2.2. By End-use
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Weight Capacity
15.10.2.2. By End-use
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Weight Capacity
15.11.2.2. By End-use
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Weight Capacity
15.12.2.2. By End-use
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Weight Capacity
15.13.2.2. By End-use
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Weight Capacity
15.14.2.2. By End-use
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Weight Capacity
15.15.2.2. By End-use
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Weight Capacity
15.16.2.2. By End-use
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Weight Capacity
15.17.2.2. By End-use
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Weight Capacity
15.18.2.2. By End-use
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Weight Capacity
15.19.2.2. By End-use
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Weight Capacity
15.20.2.2. By End-use
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Weight Capacity
15.21.2.2. By End-use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Weight Capacity
16.3.3. By End-use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Invacare Corporation
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Hill-Rom Holdings
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Stryker
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Arjo
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Drive DeVilbiss Healthcare
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. GF Health Products, Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Zhangjiagang Medi
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. COBI REHAB
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. ALERTA
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. ROTEC INTERNATIONAL
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Bariatric Beds Market
